Viking Therapeutics, Inc. — All Filings
621 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
25-NSE
3
3/A
4
4/A
424B3
424B4
424B5
8-A12B
8-K
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFR14A
DRS
EFFECT
FWP
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3ASR
S-3MEF
S-8
S-8 POS
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-002541 | Mar 27, 2026 | — |
| 4 | 4 | 0001193125-26-100581 | Mar 10, 2026 | — |
| 8-K | 8-K | 0001193125-26-046536 | Feb 11, 2026 | — |
| 10-K | 10-K | 0001193125-26-046876 | Feb 11, 2026 | Dec 31, 2025 |
| 3 | 3 | 0001193125-26-023025 | Jan 26, 2026 | Jan 12, 2026 |
| 4 | 4 | 0001193125-26-023030 | Jan 26, 2026 | Jan 12, 2026 |
| 4 | 4 | 0001193125-26-003108 | Jan 5, 2026 | Jan 2, 2026 |
| 4 | 4 | 0001193125-26-003110 | Jan 5, 2026 | Jan 2, 2026 |
| 4 | 4 | 0001193125-26-003111 | Jan 5, 2026 | Jan 2, 2026 |
| 4 | 4 | 0001193125-26-003112 | Jan 5, 2026 | Jan 2, 2026 |
| 4 | 4 | 0001193125-26-003109 | Jan 5, 2026 | Jan 2, 2026 |
| 4 | 4 | 0001193125-26-003115 | Jan 5, 2026 | Jan 2, 2026 |
| 144 | — | 0001950047-26-000104 | Jan 5, 2026 | — |
| 144 | — | 0001950047-26-000106 | Jan 5, 2026 | — |
| 4 | 4 | 0001193125-26-003116 | Jan 5, 2026 | Jan 2, 2026 |
| 144 | — | 0001950047-26-000105 | Jan 5, 2026 | — |
| 4 | 4 | 0001193125-26-003113 | Jan 5, 2026 | Jan 2, 2026 |
| 144 | — | 0001950047-26-000086 | Jan 2, 2026 | — |
| SCHEDULE 13G/A | — | 0000315066-25-002861 | Nov 5, 2025 | — |
| 4 | 4 | 0001193125-25-254304 | Oct 28, 2025 | Oct 27, 2025 |
| 144 | — | 0001950047-25-008233 | Oct 28, 2025 | — |
| 144 | — | 0001950047-25-008234 | Oct 28, 2025 | — |
| 144 | — | 0001950047-25-008235 | Oct 28, 2025 | — |
| 4 | 4 | 0001193125-25-254298 | Oct 28, 2025 | Oct 27, 2025 |
| 4 | 4 | 0001193125-25-254299 | Oct 28, 2025 | Oct 27, 2025 |
| 4 | 4 | 0001193125-25-254300 | Oct 28, 2025 | Oct 27, 2025 |
| 144 | — | 0001950047-25-008201 | Oct 27, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-247059 | Oct 23, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-246775 | Oct 22, 2025 | — |
| 8-K | 8-K | 0001607678-25-000003 | Aug 19, 2025 | — |
| SCHEDULE 13G/A | — | 0000315066-25-002155 | Aug 6, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-097950 | Jul 23, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0000950170-25-097885 | Jul 23, 2025 | — |
| 4 | 4 | 0000950170-25-093793 | Jul 3, 2025 | Jul 2, 2025 |
| 4 | 4 | 0000950170-25-093792 | Jul 3, 2025 | Jul 2, 2025 |
| 144 | — | 0001950047-25-004825 | Jul 3, 2025 | — |
| 144 | — | 0001950047-25-004828 | Jul 3, 2025 | — |
| 144 | — | 0001950047-25-004829 | Jul 3, 2025 | — |
| 4 | 4 | 0000950170-25-093791 | Jul 3, 2025 | Jul 2, 2025 |
| 8-K | 8-K | 0000950170-25-077865 | May 27, 2025 | May 20, 2025 |
| SCHEDULE 13G/A | — | 0000315066-25-001596 | May 12, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-058129 | Apr 24, 2025 | Mar 31, 2025 |
| SCHEDULE 13G/A | — | 0002052113-25-000430 | Apr 23, 2025 | — |
| 8-K | 8-K | 0000950170-25-057323 | Apr 23, 2025 | Apr 18, 2025 |
| 8-K | 8-K | 0000950170-25-057337 | Apr 23, 2025 | — |
| DEFR14A | DEFR14A | 0000950170-25-057535 | Apr 23, 2025 | — |
| DEFA14A | DEFA14A | 0000950170-25-057537 | Apr 23, 2025 | — |
| UPLOAD | — | 0000000000-25-004171 | Apr 21, 2025 | — |
| 4 | 4 | 0000950170-25-053867 | Apr 14, 2025 | Apr 11, 2025 |
| CORRESP | — | 0000950170-25-052253 | Apr 8, 2025 | — |